miércoles, 21 de septiembre de 2011

Drugs Approved for Soft Tissue Sarcoma - National Cancer Institute


Drugs Approved for Soft Tissue Sarcoma
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for soft tissue sarcoma. Soft tissue sarcomas include gastrointestinal stromal tumors (GIST), AIDS-related Kaposi sarcoma, rhabdomyosarcoma, and uterine sarcoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in soft tissue sarcoma that are not listed here.

On this page:
 Drugs Approved for Adult And Childhood Sarcoma
Adriamycin PFS (Doxorubicin Hydrochloride)
Adriamycin RDF (Doxorubicin Hydrochloride)
Doxorubicin Hydrochloride
Drugs Approved for AIDS-related Kaposi Sarcoma
Dox-SL (Doxorubicin Hydrochloride Liposome)
Doxil (Doxorubicin Hydrochloride Liposome)
Doxorubicin Hydrochloride Liposome
Evacet (Doxorubicin Hydrochloride Liposome)
LipoDox (Doxorubicin Hydrochloride Liposome)
Paclitaxel
Taxol (Paclitaxel)
Velban (Vinblastine Sulfate)
Velsar (Vinblastine Sulfate)
Vinblastine Sulfate


Drugs Approved for Gastrointestinal Stromal Tumors
Gleevec (Imatinib Mesylate)
Imatinib Mesylate
Sunitinib Malate
Sutent (Sunitinib Malate)
Drugs Approved for Rhabdomyosarcoma
Vincasar PFS (Vincristine Sulfate)
Vincristine Sulfate



Drugs Approved for Soft Tissue Sarcoma - National Cancer Institute

No hay comentarios:

Publicar un comentario